학술논문

Polyamine Metabolites as Biomarkers in Head and Neck Cancer Biofluids
Document Type
article
Source
Diagnostics. 12(4)
Subject
Medical Biochemistry and Metabolomics
Biomedical and Clinical Sciences
Cancer
Dental/Oral and Craniofacial Disease
Prevention
Rare Diseases
4.2 Evaluation of markers and technologies
Detection
screening and diagnosis
Good Health and Well Being
head and neck cancer
biomarkers
metabolomics
polyamines
saliva
urine
Clinical sciences
Language
Abstract
Background: Novel, non-invasive diagnostic biomarkers that facilitate early intervention in head and neck cancer are urgently needed. Polyamine metabolites have been observed to be elevated in numerous cancer types and correlated with poor prognosis. The aim of this study was to assess the concentration of polyamines in the saliva and urine from head and neck cancer (HNC) patients, compared to healthy controls. Methods: Targeted metabolomic analysis was performed on saliva and urine from 39 HNC patient samples and compared to 89 healthy controls using a quantitative, targeted liquid chromatography mass spectrometry approach. Results: The metabolites N1-acetylspermine (ASP), N8-acetylspermidine (ASD) and N1,N12-diacetylspermine (DAS) were detected at significantly different concentrations in the urine of HNC patients as compared to healthy controls. Only ASP was detected at elevated levels in HNC saliva as compared to healthy controls. Conclusion: These data suggest that assessment of polyamine-based metabolite biomarkers within the saliva and urine warrants further investigation as a potential diagnostic in HNC patients.